Application of Patient-Reported Outcome Measurements in Clinical Trials in China

IMPORTANCE: Regulatory authorities, industry peers, and international health policies have emphasized the value of assessing patient-reported outcomes (PROs) in clinical studies. Despite the increase in the number of clinical studies in the last decade in China, little is known about the extent of t...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Hui, Yao, Mi, Gu, Xiaodan, Liu, Mingrui, Zeng, Ruifeng, Li, Qin, Chen, Tingjia, He, Wen, Chen, Xiao, Yuan, Gang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9096600/
https://www.ncbi.nlm.nih.gov/pubmed/35544134
http://dx.doi.org/10.1001/jamanetworkopen.2022.11644

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9096600/
https://www.ncbi.nlm.nih.gov/pubmed/35544134
http://dx.doi.org/10.1001/jamanetworkopen.2022.11644

Ejemplares similares